INTRODUCTION
Understanding the mechanisms that activate HIV-1 is central to effective eradication of the HIV-1 disease (reviewed by Tang et al., 1999) . Clinical studies have shown that in infected individuals, the use of highly potent antiviral agents can suppress HIV-1 replication and reduce the levels of HIV-1 RNA to below the limits of detection in blood (see, for example, Chun et al., 1997a,b; Perelson et al., 1997; Wong et al., 1997) . However, evidence suggests that the current combination of drug regimens do not fully eradicate the disease. In studies of the peripheral blood of patients with complete and sustained plasma viremia, evidence supported the existence of replication-competent and latent forms of the virus (Chun et al., 1997a,b; Perelson et al., 1997; Wong et al., 1997) . Latent forms of the virus may include transcriptionally dormant, integrated proviral DNA, and low levels of persistent active virus (Chun et al., 1997a,b) . In vitro assays have shown that upon cellular stimulation, latent HIV-1 is activated to produce elevated levels of infectious particles (Wong et al., 1997; Chun et al., 1997a,b) .
Depending on cell type, a variety of biological and chemical agents can activate HIV-1 transcription leading to virus production (reviewed by Tang et al., 1999) . Activators of HIV-1 include cytokines, the tumor-promoting agent PMA, and a group of bacterial lipopolysaccharides collectively referred to as LPS (reviewed by Roebuck and Saifuddin, 1999) . Long-terminal repeat (LTR)-directed transcription is regulated through several pathways involving various cellular proteins including factors that direct chromatin remodeling, factors that serve as components of the basal transcriptional machinery, and transcription factors that act through protein-DNA, proteinprotein, and protein-ligand interactions (reviewed by Marzio and Giacca, 1999; Roebuck and Saifuddin, 1999) .
The HIV-1 LTRs are selectively recognized by several cellular transcription factors including Sp1, NF-B, USF, and NF-IL6 (Jones et al., 1986; Nabel and Baltimore, 1987; Lu et al., 1990; Tesmer et al., 1993) . Two Sp1 sites are in the immediate upstream of the TATA element, regulated by the components of the basal transcriptional machinery. Two NF-B sites act in cellular responses controlled by stimulating agents including TNF␣, LPS, and PMA (Nabel and Baltimore, 1987; Pomerantz et al., 1990) . USF binds an E-box upstream of the NF-B sites. USF has been implicated in exerting either negative or positive control on HIV-1 transcription (Lu et al., 1990; Giacca et al., 1992; di Fagagna et al., 1995; Naghavi et al., 2001) .
The LTR of HIV-1 variants may include one or several sites for binding NF-IL6 (Tesmer et al., 1993) . The major NF-IL6-binding site (site I) overlaps the USF-binding sequence. This site has been found in the LTR of several HIV-1 variants (Tesmer et al., 1993; Mondal et al., 1995; Henderson et al., 1995; Ruocco et al., 1996) and appears in all B subtype HIV-1 isolates from Southern Africa (Zacharova et al., 1997) . The LTR of HIV-1 variants may include a second NF-IL6-binding site (site II) in the immediate upstream of the NF-B-binding sequences (Tes-mer et al., 1993; Mondal et al., 1995; Henderson et al., 1995; Ruocco et al., 1996) . Another NF-IL6-binding sequence (site III) appears further upstream. However, this sequence does not conform to the NF-IL6 consensus-binding site and interacts poorly with NF-IL6 (Tesmer et al., 1993) .
Understanding of how NF-IL6 regulates HIV-1 transcription is central to identifying the pathways through which HIV-1 could be activated since studies have shown that NF-IL6, also known as human C/EBP␤, plays a key role in the control of gene expression in cellular responses mediated by cytokines and LPS as a consequence of bacterial infection (Akira et al., 1990; Akira and Kishimoto, 1992) . However, the mechanism of LTR regulation by NF-IL6 is not fully understood. Specifically, the results of several studies have shown that in transient expression assays, activation of HIV-1 expression by NF-IL6 can occur in the absence of the NF-IL6-binding sequences, suggesting that NF-IL6 might exert control through other regulators of HIV-1 transcription (see, for example, Tesmer et al., 1993; Mondal et al., 1995; Ruocco et al., 1996; Tesmer and Bina, 1996; Schwartz et al., 2000) . However, the results of studies from another laboratory indicated that in human monocyte/macrophages (U937 cells) stimulated with LPSϩPMA, at least one NF-IL6-binding sequence was required for the upregulation of HIV-1 expression by NF-IL6 (Henderson et al., 1995 (Henderson et al., , 1996 Henderson and Calame, 1997) .
Since more recent data indicated that in U937 cells stimulated with LPSϩPMA, the endogenous NF-IL6 could act through functional interactions with other regulators of LTR-mediated transcription (Yang, 1999) , we examined the regulation of HIV-1 transcription in activated U937 cells by using a decoy against NF-IL6. DNAbinding assays were done to closely evaluate interactions of nuclear proteins with the LTR regions implicated in binding NF-IL6. Transient expression experiments were done to examine potential mechanism of NF-IL6-directed regulation of HIV-1 transcription.
RESULTS
Interactions of nuclear proteins with the Ϫ189/Ϫ147 region of HIV-1 LTR For studies of HIV-1 regulation in activated monocyte/ macrophages, experiments were designed to closely examine protein interactions with DNA fragments containing the NF-IL6 and USF sites in the Ϫ189/Ϫ147 region of the HIV-1 LTR (Fig. 1) . One set of assays analyzed the wild-type DNA in electrophoretic mobility shift assays (EMSAs). With nuclear extracts from unstimulated cells, the probe produced a cluster of closely spaced bands (Fig. 2) . With extracts from cells stimulated with LPSϩPMA, the probe produced a similar pattern of protein-DNA interactions (Fig. 2) . In the assays, increasing amounts of the cold probe competed effectively for formation of the major bands ( Fig. 2A , Lanes 2, 3, 9, 10). Sequences with an insertion in the NF-IL6 site, but an intact E-Box (providing the USF site), also competed effectively for complex formation ( Fig. 2A , Lanes 4, 5, 11, 12) . In contrast, a fragment containing an insertion in the E-box but an intact NF-IL6 site could not compete with the probe for protein binding ( Fig. 2A Lanes 6 , 7, 13, 14) .
Specific antibodies were added to the DNA-binding reactions to identify the major components of the complexes formed with the wild-type Ϫ189/Ϫ147 region (Fig.  2B ). In the assays, anti-USF reacted with nearly all of the complexes formed with the wild-type sequence (Fig. 2B , Lanes 5 and 12), indicating that USF was a major component of the bands detected in EMSAs. A fraction of the bands was supershifted with anti-USF-1 (Lanes 2 and 9); the other fraction reacted with anti-USF-2 (Lanes 3 and 10). Inclusion of antibody to both USF-1 and USF-2 shifted nearly all of the complexes formed with the wildtype probe (Lanes 5 and 12). With anti-C/EBP␤, we did not detect supershifted bands in assays analyzing extracts from unstimulated cells (Lane 4). With extracts from cells stimulated with LPSϩPMA, anti-C/EBP␤ produced faint, barely detectable, supershifted bands (Fig.  2B, Lane 11) . Overall, the results implied that the complexes formed with the wild-type DNA contained primarily USF1 and USF2.
To further evaluate this finding, for EMSAs we designed a probe containing an insertion in the USF site while maintaining the NF-IL6-binding sequence intact. This probe was incubated with nuclear extracts prepared from stimulated or unstimulated U937 cells. The bands produced with extracts from unstimulated cells (0 h) were diffused and relatively low in intensity (Fig. 3 , Lane 1). Anti-C/EBP␤ reacted with a fraction of the diffused bands (Fig. 3, Lane 2) , indicating that the extracts from unstimulated cells contained low levels of NF-IL6. Significantly higher amounts of NF-IL6-containing complexes were obtained with extracts from cells stimulated with both LPS and PMA (Fig. 3 , Lanes 3 and 5). Generally, the fraction of NF-IL6-containing complexes increased as a function of cellular stimulation time; see, for example, the level observed with extracts from cells stimulated for 66 h with LPSϩPMA (Fig. 3 , Lanes 5 and 6).
Additional assays evaluated protein interactions with a probe containing an insertion in the NF-IL6 site while maintaining the USF site intact. The protein-binding pattern detected for this probe (data not shown) was similar to the pattern observed for the wild-type sequence (Fig.  2) . Overall the data indicated that in studies of extracts from U937 cells stimulated with LPSϩPMA, USF1 and USF2 dominated the complexes formed with the wildtype sequence (Fig. 2 ) even though the sequence contained an intact NF-IL6 site and even though the production of NF-IL6 was clearly induced in the stimulated cells (Fig. 3) .
Regulation of HIV-1 transcription by NF-IL6 in monocyte/macrophages stimulated with LPSϩPMA
To test the involvement of NF-IL6 in regulation of HIV-1 transcription, we designed an experiment using a decoy to inhibit the activity of NF-IL6 in U937 cells stimulated with LPSϩPMA. This experiment was designed since supershift assays did not detect significant amounts of NF-IL6 in complexes formed with the native Ϫ189/Ϫ147 region of the LTR (Fig. 2) . The LTR of the HIV-1 variant examined in functional assays ( Fig. 1) included a single site for binding NF-IL6 (site I, Ϫ173 to Ϫ165), and contained a naturally occurring mutation in the NF-IL6 site II, flanking the NF-B-binding sequences (Tesmer et al., 1993; Tesmer and Bina, 1996) .
The design of functional assays relied on an expression construct (CMV500-4hep-CEBP) that produced in cells a peptide inhibiting the activity of C/EBPs. The inhibitor included acidic residues in the N-terminal region of the Leucine Zipper (Krylov et al., 1995) . We expected that the inhibitor would act as a dominant negative regulator of NF-IL6 by forming a coiled-coiled structure with the bZIP region to interfere with the DNAbinding and transactivation properties of NF-IL6 (Krylov et al., 1995) . In designing the experiment, we reasoned that if NF-IL6 functioned in the activation of HIV-1 gene expression in stimulated cells, then production of the 4hep-CEBP peptide should downregulate LTR-mediated transcription in stimulated cells through dimerization with the induced NF-IL6. To test this hypothesis, in functional assays increasing amounts of CMV500-4hep-CEBP were cotransfected with a selected reporter construct. The assays were supplemented with the empty CMV vector to maintain a constant amount of DNA. Subsequently the transfected cells were mock stimulated or stimulated with LPSϩPMA, to induce the production of endogenous NF-IL6 (Fig. 4) .
The effect of the decoy was tested on the activity of two reporter constructs: a wild-type construct (pC15⌬XE) and a deletion mutant (pC15⌬XP). The wild-type construct contained the LTR segment between nucleotides Ϫ339 and ϩ83. The deletion mutant lacked the USF site, the NF-IL6 site, and sequences further upstream (Fig. 1) . In transient expression assays, in the absence of the decoy, both constructs responded positively to LPS and PMA stimulation, as expected (Fig. 4) . Increasing amounts of the decoy reduced significantly the activity of the wild-type construct, supporting a central role for NF-IL6 in activation of HIV-1 transcription in monocyte/ macrophages stimulated with LPSϩPMA (Fig. 4) . Increasing amounts of the decoy also reduced gene expression from the wild-type construct in mock-stimulated cells, indicating that the low levels of NF-IL6 in unstimulated cells (Fig. 3) contributed to the background level of HIV-1 transcription in unstimulated monocyte/macrophages (Fig. 4) . We noted that in the assays, increasing amount of the decoy also reduced the activity of the deletion construct (pC15⌬XP) that lacked sequences upstream position Ϫ163: including the NF-IL6 and USF site (Figs. 1 and 4) . Krylov et al. (1995) have shown that in functional assays the decoy acted selectively against transactivators containing C/EBP zipper but not those containing GCN4 zipper.
The results of the experiments described for the deletion mutant implied that the endogenous NF-IL6 was acting in the absence of a specific site for binding NF-IL6, since the LTR variant analyzed in the assays included a point mutation in the NF-IL6-binding sequence (site II) flanking the NF-B sites (Fig. 1) . This sequence was expected not to bind NF-IL6. Nonetheless, we designed experiments to evaluate directly the interactions of nuclear extracts with the segment (Ϫ114/Ϫ106) that flanks the NF-B site (Fig. 5) , to test whether the naturally mutated segment interacted with NF-IL6. For comparative analysis, we also synthesized a pair of oligos (mC3LTR) containing a five-base substitution in the NF-B flanking sequences since previous studies found that this substitution significantly altered the functional activity of the LTR in responses mediated by NF-IL6 (Henderson et al., 1995 (Henderson et al., , 1996 Henderson and Calame, 1997) .
In EMSAs, with nuclear extracts from unstimulated or stimulated cells, the probe consisting of the Ϫ114/Ϫ106 region of the variant LTR produced a nonspecific band but not any specific complex (Fig. 5B , Lanes 7 to 12). Therefore, as predicted, the natural LTR variant analyzed in our functional assays did not contain the NF-IL6-binding sequence adjacent to the NF-B sites. However, in the assays, the mC3LTR oligos interacted with proteins in nuclear extracts from unstimulated cells to produce a specific band and a nonspecific band (Fig. 5A , Lanes 1 to 6). Formation of the specific complex could be competed with the cold probe defining the m3LTR muta-
Effect of a decoy (CMV500-4hep-CEBP) against NF-IL6 on the wild-type LTR and a deletion mutant. The assays analyzed the functional activity of two constructs (pC15⌬XP and pC15⌬XE) in unstimulated U937 cells (dash line) and in cells stimulated with LPSϩPMA (solid line). The assays were done as a function of increasing amounts of CMV500-4hep-CEBP, an inhibitor of C/EBPs (Krylov et al., 1995) . The construct pC15⌬XE represents the wild-type DNA; pC15⌬XP has a deletion extending to position Ϫ163 (Fig. 1). tion (Fig. 5A , Lane 2) but not with the naturally occurring sequence (Ϫ114/Ϫ106(⌬XE)) containing a mismatch with the consensus NF-IL6-binding site (Fig. 5A, Lane 3) . The results suggest that the engineered mutation in m3LTR created a binding site for another nuclear protein. Furthermore, we observed a different DNA-binding pattern when the mC3LTR oligos were incubated with nuclear extracts from stimulated cells (Fig. 5C ). With nuclear proteins from stimulated cells, the probe produced lowintensity diffused bands, migrating above the nonspecific band (Fig. 5C, Lane 5) . The cold probe eliminated the specific complexes formed with mC3LTR while the Ϫ114/ Ϫ106(⌬XE) oligos did not (Fig. 5) . Anti-C/EBP␤ supershifted the diffused bands produced with extracts from stimulated cells. The results implied that the complex formed with the mC3LTR and nuclear proteins from stimulated cells included low levels of NF-IL6.
Functional interactions involving NF-IL6
The experiments in the previous section showed that in cells stimulated with LPSϩPMA, a decoy against NF-IL6 reduced the activity of a construct that did not contain consensus sites for binding NF-IL6 (Fig. 4) . The results implied that when examined in the context of a wild-type LTR, in stimulated cells NF-IL6 could act in the absence of consensus NF-IL6-binding elements. In another set of assays we tested the activity of a construct containing the wild-type and mutated Ϫ189/Ϫ147 segment, cloned in the immediate upstream of the basal LTR sequences (Ϫ40 to ϩ83, Fig. 6 ). Under our standard transfection assays, using 5 g of reporter DNA, the native Ϫ189/ Ϫ147 region was active, but the assays did not detect a response to cellular stimulation with LPSϩPMA (Fig. 7) . A very small response was observed when 10 g of the construct was analyzed in the assays (Fig. 7) .
In studies of mutated constructs (Fig. 6 ), CAT activity was nearly abolished when an insertion was made in either the USF site or the NF-IL6 site (Fig. 7) . This finding may imply that the NF-IL6 site was responsible for the activity obtained for the isolated Ϫ189/Ϫ147 region. However we noted that gene activity and response to cellular stimulation was not obtained for the construct The probe mC3LTR contained a 5-bp substitution in the NF-IL6 consensus site in the Ϫ114 to Ϫ106 region (Henderson et al., 1995 (Henderson et al., , 1996 Henderson and Calame, 1997) . (B) The probe Ϫ114/Ϫ106(⌬XE) is from the Ϫ114 to Ϫ106 region of the variant analyzed in our functional assays. Each probe was incubated with nuclear extracts from unstimulated U937 cells (Ϫ) or from cells stimulated (ϩ) for 20 h with LPSϩPMA. Some reactions contained a competitor DNA (Ϫ114 to Ϫ106 oligos, or mC3LTR oligos), as indicated above the corresponding lanes. The arrow points to the specific complex generated from interactions of the mC3LTR oligos with proteins in extracts from unstimulated cells; brace marks the position of diffusely migrating specific bands; N.S. points to a nonspecific band. (C) The mC3LTR oligos were analyzed using nuclear extracts from U937 cells stimulated, for 48 h, with LPSϩPMA. The reactions in Lanes 2-8 contained a competitor DNA (S.P.), Ϫ114/Ϫ106 oligos, or the NF-B-binding sequences, as indicated above the corresponding lanes. Lane 9 contained antibody (␣A) to C/EBP␤. The brace marks the position of diffusely migrating specific bands produced with nuclear extracts from U937 cells stimulated with LPSϩPMA. The arrow on the left points to the specific complex generated from interactions of the mC3LTR oligos with proteins in extracts from unstimulated cells; N.S. points to a nonspecific band.
containing an intact NF-IL6 site but an insertion in the USF site (Fig. 7) . In DNA-binding assays, mutations in the USF site caused high levels of NF-IL6-containing complexes in studies of extracts from stimulated cells (Fig. 3) . The results indicated that in the context of isolated Ϫ189/ Ϫ147 region, USF did not act in the absence of NF-IL6 and NF-IL6 did not act in the absence of USF. This result suggests functional interactions of NF-IL6 and USF.
The data prompted assays to evaluate functional interactions of NF-IL6 and NF-B in stimulated monocyte/ macrophages (Fig. 8) . Previously several studies examined physical and functional interactions of NF-IL6 with subunits of NF-B (LeClair et al., 1992; Ruocco et al., 1996) . We wished to test the effect of exogenous NF-IL6 on the activity of HIV-1 B sites in monocyte/macrophages stimulated with LPSϩPMA. For this analysis, native and mutated NF-B sites (Nabel and Baltimore, 1987) were cloned in the immediate upstream of the basal region of the LTR (Fig. 6 ) to evaluate their relative activities in cotransient expression assays.
In the assays, as expected, the isolated NF-B sites responded to cellular stimulation with LPSϩPMA, while mutated NF-B sites did not (Fig. 8) . In unstimulated and stimulated cells, exogenous NF-IL6 increased the activity of the CAT gene driven by native NF-B sites (Fig. 8) . In cells stimulated with LPSϩPMA, the response to NF-IL6 was relatively high. In stimulated cells, the construct containing mutated B sites also responded to NF-IL6 (Fig. 8) . A small response also was detected for the basal region, as previously observed (Tesmer and Bina, 1996) . FIG. 6 . Organization of constructs containing isolated segments from the LTR. For functional studies, several segments were cloned upstream the basal sequences (Ϫ40 to ϩ83). One segment (Ϫ108 to Ϫ78) included the NF-B sites. Another segment (Ϫ189 to 147) included the overlapping NF-IL6 and USF sites (Fig. 1) . Mutated segments contained replacements in the NF-B sites, an insertion in the NF-IL6 site, or an insertion in the USF site. In the diagram, the modified sequences are marked by an X. The basal sequences are designated as LTRb.
FIG. 7.
Functional activity of isolated NF-IL6 and USF sites. Functional assays evaluated the following constructs: Ϫ189/Ϫ147wtLTRb, the native sequence; Ϫ189/Ϫ147mNF-IL6LTRb, containing an insertion in the NF-IL6 site; Ϫ189/Ϫ147mEboxLTRb, containing an insertion in the E box defining the USF site. LTRb corresponds to the basal segment (Fig. 6) . The experiments examined two different concentrations (5 and 10 g) of each construct in stimulated cells (ϩ) and in unstimulated cells (Ϫ).
FIG. 8.
The effect of exogenous NF-IL6 on gene expression driven by the NF-B sites. The constructs included intact or mutated NF-B sites cloned upstream the basal region (Fig. 6) . The assays were done in unstimulated U937 cells (shown as Ϫ) or in LPS and PMA stimulated cells (shown as ϩ), in the presence (ϩ) or absence of an NF-IL6 producing construct (CMV NF-IL6).
DISCUSSION
The results of the studies shown in this article agree with several lines of evidence, indicating that the mechanism of regulation of HIV-1 transcription by NF-IL6 is complex. To regulate LTR-mediated transcription, NF-IL6 can functionally interact with Sp1 (Tesmer and Bina, 1996; Schwartz et al., 2000) , with USF ( Fig. 7) , with NF-B ( Fig. 8 ; also see Mondal et al., 1995; Ruocco et al., 1996) , with COUP-TF (Schwartz et al., 2000) , and with ATF/CREB family members (Ross et al., 2001) . Thus, while in microglial and oligodendroglioma cells, NF-IL6 functioned as a potent activator of LTR-driven transcription and NF-IL6 could act via the minimal Ϫ40/ϩ80 region of the LTR, implying that the NF-IL6-binding elements were not essential for LTR activation by NF-IL6 (Schwartz et al., 2000) . Furthermore, functional interactions of NF-IL6 and Sp1 led to synergistic transcriptional activation of the LTR in oligodendroglioma cells (Schwartz et al., 2000) . Similarly, in human hepatoma HepG2 cells, NF-IL6 functionally interacted with Sp1 to upregulate transcription through the minimal Ϫ40/ϩ83 region of the LTR (Tesmer and Bina, 1996) . In activated Jurkat cells, exogenous NF-IL6 significantly increased the level of the LTR response to cellular stimulation through a mechanism that did not require the NF-IL6-binding elements (Buckner et al., 2002) . In NTera-2 cells (Ruocco et al., 1996) and in activated monocyte/macrophages (Fig. 8) , NF-IL6 could upregulate LTR-mediated transcription through functional interactions with NF-B.
Evidence has further shown that in some cases NF-IL6 can act indirectly to regulate the expression of cellular genes. For example, in beta pancreatic cells, NF-IL6 inhibited transcription of the rat insulin I gene not through binding DNA but through interaction with a heptad leucine repeat sequence within the activation domain 2 of the bHLH transcription factor E47 (Lu et al., 1997) . Studies of the rat insulin gene indicate that the leucine zipper in NF-IL6 and its family members (C/EBPs) could play multiple roles in regulation of gene expression.
In addition to functional or physical interactions with several transcription factors, including E47 (Lu et al., 1997) , the p50 subunit of NF-B (LeClair et al., 1992; Ruocco et al., 1996) , COUP-TF (Schwartz et al., 2000) , and ATF/CREB family members (Ross et al., 2001) , NF-IL6 interacts with mediators of transcription. For example, the chicken homolog of NF-IL6 interacts with p300/ CREB-binding protein CBP (Mink et al., 1997) . Two-hybrid-type experiments supported a critical role of the amino terminal sequences of the chicken bZIP protein in interactions with CBP (Mink et al., 1997) and implied that transcriptional transactivation by CBP might require intact homodimers of the bZIP protein. Extending these results to studies of HIV-1 regulation would suggest that heterodimers of NF-IL6 that lack the amino-terminus of the protein should be inactive in LTR-mediated transcription. Consistent with this interpretation is repression of LTR-mediated transcription by heterodimers consisting of NF-IL6 and a decoy against NF-IL6 (Fig. 4) .
For studies of regulation of HIV-1 transcription by NF-IL6, a study made two-site-directed nucleotide replacements to derive constructs that lacked NF-IL6 site I or site II (Henderson et al., 1995) . One replacement (mc2) was made to destroy the NF-IL6-binding sequence that overlaps the USF site. The other (mc3) was made to destroy the NF-IL6-binding sequence that flanks the NF-B sites. The constructs and their derivatives have been used in several studies (see, for example, Henderson et al., 1995 Henderson et al., , 1996 Henderson and Calame, 1997) . The results of these studies indicated that one NF-IL6-binding sequence was required for the regulation of HIV-1 transcription by NF-IL6. In contrast, our data revealed that a decoy against the endogenous NF-IL6 reduces gene activation by a wild-type LTR and reduced the activity of a deletion construct lacking binding sites for NF-IL6. The results indicate that in activated monocyte/ macrophages, NF-IL6 may act in a site-independent fashion (Fig. 4) .
To understand the reason for the disagreements in the literature, we have inspected and closely examined the sequence of mc2 and mc3 analyzed in previous reports (Henderson et al., 1995 (Henderson et al., , 1996 Henderson and Calame, 1997) . Our studies indicate that creation of mc3 resulted in a binding site for a cellular protein (Fig. 5) . It seems possible that interactions of this protein with mc3 may affect the results of assays using mc3 and its derivatives.
Inspection of the sequence of mc2 indicates that in addition to destroying the NF-IL6-binding sequence that overlaps the USF site, mc2 destroys a sequence that can potentially interact with TCF20. A binding site for this novel transcription factor exists in the LTR of some HIV-1 variants. In fact, a partial cDNA for TCF20 was isolated using a DNA segment that included the NF-IL6 and USF site, from the LTR of an HIV-1 variant (Rajadhyaksha et al., 1998) . TCF20, also known as SPBP (Sanz et al., 1995) , is relatively large. This novel transcription factor includes several domains that stimulate the activity of various transcription factors including c-Jun, Ets1, Sp1, and Pax6 (Rekdal et al., 2000) . TCF20/SPBP also interacts with RNF4 (SNURF), which has been shown to interact with steroid hormone receptors and Sp1 (Lyngso et al., 2000) . Evidence suggests that NF-IL6 can tether to TCF20 and thus may act indirectly to exert control on LTR-mediated transcription (J. Gu and M. Bina, unpublished observations).
As observed for NF-IL6, USF also has been shown to affect LTR-directed transcription independent of sequence variations that would reduce interactions of USF with HIV-1 DNA (Naghavi et al., 2001) . In T cells, USF functionally interacted with Ets-1 to upregulate LTR-directed transcription (Sieweke et al., 1998) . Evidence in-dicated that in the absence of USF site, USF upregulated LTR-mediated transcription through functional interactions with factors that bind the initiator element in the basal region of the HIV-1 LTR (Du et al., 1993) .
In fact, several studies support a central role for the basal segment in the control of HIV-1 transcription (Kashachi et al., 1994; Estable et al., 1996; Tesmer and Bina, 1996; Schwartz et al., 2000) . The basal segment may play a crucial role in the activation of HIV-1 transcription since the rapidly evolving HIV-1 variants often can tolerate large deletions and mutations in the LTR and remain responsive to cellular stimulation (Kashachi et al., 1994; Estable et al., 1996) . In this context, the site-independent pathway of HIV-1 regulation by NF-IL6 might be significant. Specifically, in the LTR of rapidly evolving HIV-1 variants, the sequence elements that bind NF-IL6 can change (Estable et al., 1996; Ross et al., 2001) , but in activated cells, NF-IL6 would act to upregulate the production of variants that contain a native basal region and one or more intact sites for other transcription factors that bind specific sequence elements in the LTR. This mechanism predicts a central role for NF-IL6 in supporting the production and propagation of rapidly evolving HIV-1 variants in HIV-1-infected individuals, particularly when they suffer from episodes of infection with gramnegative bacteria (Pomerantz et al., 1990) and when the NF-IL6 gene is upregulated in the course of immune and inflammatory responses.
MATERIALS AND METHODS

Cell culture
Human promonocytic cell line U937 (American Type Culture Collection) was grown in RPMI 1640 media (Irvine Scientific) supplemented with 10% heat-inactivated fetal bovine serum (Gibco), 100 U/mL penicillin, 100 g/mL streptomycin, 5.5 mM ␤-mercaptoethanol, and 1 mM sodium pyruvate (Gibco). For cellular stimulation, LPS stock was prepared by dissolving lyophilized LPS (Escherichia coli strain 055:B5, Sigma) in sterile ddH 2 O. A solution (10 g/mL) of stock PMA (99%-TLC purified, Sigma) was prepared in DMSO. U937 cells were stimulated by adding aliquots of stock solution of LPS (2 g/mL final concentration) and PMA (10 ng/mL final concentration) to the culture media. Mock stimulation was performed with the solvents used for preparing LPS and PMAs.
Electrophoretic mobility shift assays
Nuclear extracts were prepared from unstimulated and LPSϩPMA-stimulated cells as previously described (Doyle et al., 1994) . For studies of NF-IL6 site I, chemical synthesis was done to produce double-stranded oligonucleotides corresponding to the Ϫ189 to Ϫ147 region of the HIV-1 long terminal repeat. The oligos were annealed and cloned.
Recombinant plasmids were sequenced to ensure accuracy (Tesmer et al., 1993) . We followed a similar strategy for obtaining a plasmid (Ϫ187/Ϫ147mNF-IL6) containing an insertion, three nucleotides (ATTTCTAGATCA), in the Ϫ189 to Ϫ147 region of the HIV-1 LTR (Tesmer and Bina, 1996) . Mutated USF site (Ϫ189/Ϫ147mEbox) was obtained from cloning synthetic DNA containing an insertion, two nucleotides (CACTAGTG), in the USF site in the Ϫ189 to Ϫ147 region of the HIV-1 LTR (Tesmer and Bina, 1996) .
For studies of NF-IL6 site II, double-stranded oligonucleotides (agcttTCGAGCTTGTTACAAGGctgca top strand) were synthetically produced and cloned. The sequence, named Ϫ114/Ϫ103(⌬XE), defines the Ϫ114 to Ϫ103 region of the LTR of an HIV-1 variant containing a point mutation in the NF-IL6 site. Another sequence (agcttTCGACAGCTGTACAAGGctgca top strand) selected for analysis corresponded to mC3LTR-containing substitutions in the NF-IL6 site in Ϫ114/Ϫ103 region of the HIV-1 LTR (Henderson et al., 1995) .
The probe analyzed in EMSAs was labeled with 32 P and subsequently incubated with 4 g nuclear extracts in reactions that included 1 g poly(dI-dC) in 15 mM HEPES (pH 7.9), 80 mM NaCl, 1 mM EDTA, 1 mM DTT, 10% glycerol, and 300 g/ml BSA. The reactions were incubated on ice for 15 to 30 min. The products were separated by electrophoresis at 4°C, at 300-250 V, in 3.5% polyacrylamide gels containing 2.5% glycerol and TGE [25 mM Tris (pH 8.3), 190 mM glycine, 1 mM EDTA]. Competition experiments included unlabeled DNA fragments (either derived from a construct or chemically synthesized).
In supershift assays, the reactions were supplemented with 1 g of antibody obtained from Santa Cruz Biotechnology: anti-C/EBP␤ (catalog no. sc-150x, epitope corresponding to an amino acid sequence mapping to the carboxyl-terminus of C/EBP␤ of rat origin, differs from the corresponding human sequence by a single amino acid); anti-USF-1 (catalog no. sc-229x, epitope corresponding to an amino acid sequence mapping to the carboxyl-terminus of USF-1 of human origin); USF-2 (catalog no. sc-861x, epitope corresponding to an amino acid sequence mapping to the amino-terminus of USF-2 of mouse origin).
DNA constructs for transient expression assays
Previous reports described constructs pC15⌬XE and pC15⌬XP (Tesmer et al., 1993; Tesmer and Bina, 1996) . Briefly, the wild-type construct (pC15⌬XE) contains the LTR segment from 339 to ϩ83, cloned upstream the CAT reporter gene. The construct was made by excising the XhoI and PmlI fragment from pC15CATb (Tesmer et al., 1993) . The deletion mutant (pC15⌬XP) was made by excising the XhoI/EcoRV fragments from pC15CATb.
Several constructs were created by cloning specific LTR-derived sequences upstream the basal region: Ϫ40 to ϩ83, designated as LTRb (Fig. 6) . The constructs included the following: Ϫ189/Ϫ147wtLTRb (containing the NF-IL6 site and the USF site); Ϫ189/Ϫ147mNF-IL6LTRb (containing three nucleotide insertion in the NF-IL6 site but an intact USF site); and Ϫ189/Ϫ147mE-boxLTRb (containing an intact NF-IL6 site but two nucleotide insertion in the USF site) described above. Two other constructs contained intact and mutated NF-B sites cloned upstream basal region. Mutated NF-B sites were made as previously described (Nabel and Baltimore, 1987) .
The expression construct for producing NF-IL6 has been described (Tesmer et al., 1993) . The expression construct CMV500-4 hep-CEBP was generously provided by Dr. C. Vinson (NCI/NIH).
Transient expression assays
For functional assays, the constructs were isolated by the alkaline lysis procedure (Sambrook et al., 1989) and further purified on Qiagen DEAE columns. The constructs were further sequenced to establish accuracy. The assays were done in U937 cells. The cells were transfected by electroporation (IBI GeneZapper 450/2500). The amount of DNA used in transient expression assays was optimized in titration experiments along with appropriate controls (Tesmer and Bina, 1996; Yang, 1999) . Electroporation was done at high cell density (at or above 2 ϫ 10 7 cells/ml), at 300 V and capacitance of 700 F.
After electroporation, the cells were incubated on ice for 10 min and subsequently transferred to 10 ml of culturing RPMI 1640 media including serum. For cellular stimulation, LPS was dissolved in water (1 mg/ml) and PMA in dimethyl sulfoxide (10 g/ml). The LPS or PMA solutions were added to transfected cells to reach a final concentration of 2 g/ml for LPS and 10 ng/ml for PMA stimulation. Control mock inductions included an aliquot of the solvents used for preparing the stock solutions of the stimulating agents.
At 46-48 h after transfection, the cells were harvested and the activity of chloramphenicol acetyltransferase in cellular extracts was determined (Gorman et al., 1982; Sambrook et al., 1989; Tesmer et al., 1993) . The TLC plates of CAT assays were initially analyzed by autoradiography. Quantitative analysis was done using a Phosphoimager. Several low exposures of the plates were analyzed to ensure linearity and reproducibility. The % CAT conversion was then determined from the number of pixels corresponding to the acetylated form of chloramphenicol, and the number of pixels corresponding to the sum of acetylated and unacetylated chloramphenicol (Yang, 1999) . The data shown under Results provide the average of several independent transfection assays.
